Enhancer regulation/endogenous and synthetic enhancer compounds:
a neurochemical concept of the innate and acquired drives
by
Knoll J.
Department of Pharmacology and Pharmacotherapy,
Faculty of General Medicine, Semmelweis University,
POB 370, H-1445 Budapest, Hungary.
jozsefknoll@hotmail.com
Neurochem Res. 2003 Aug;28(8):1275-97
ABSTRACTThis review is to summarize experimental evidence and theoretical consideration in support of the concept that a mesencephalic enhancer regulation is the basis of the limited number of innate drives indispensable for the survival of the individual and the species, while a specifically organized telencephalic enhancer regulation is the basis of the acquired drives to reach an unlimited number of dispensable goals. The study is also an overview of the experimental and clinical data supporting the proposal that, due to the progressive decay of the mesencephalic enhancer regulation with the passing of time, the prophylactic administration of a synthetic enhancer substance [(-)-deprenyl, (-)-BPAP] during postdevelopmental life could significantly slow the age-related decay of behavioral performances, prolong life, and prevent the precipitation or delay the onset of Parkinson's disease and Alzheimer's disease.Review
Antiaging
The cheese effect
Alzheimer's disease
Desmethylselegiline
Selegiline and nitric oxide
Selegiline for longer-lived flies
Selegiline and life-expectancy
Selegiline as an immunostimulant
Selegiline for cocaine dependence
Selegiline and Parkinson's disease
Selegiline, growth hormone and ratsand further reading
Refs
HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World
The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family
